Tortugas Neuroscience
Last verified 2026-05-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $106.0Mattributed |
|---|---|
| Latest round | series-a, $106.0M, 2026-04-24attributed |
| Founded | 2024 |
| Headquarters | Cambridge |
| Industry | bio |
| Stage | series-a |
| Website | tortugasneuroscience.com |
Tortugas Neuroscience develops closed-loop neurostimulation devices for treatment-resistant psychiatric disorders, beginning with major depressive disorder. Its implant continuously monitors neural biomarkers and adjusts stimulation parameters in real time, unlike conventional DBS devices that deliver fixed open-loop pulses.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-24 | series-a | $106.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $106.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $106.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | tortugasneuroscience.com, read 2026-05-13 |
| Description | self-reported | tortugasneuroscience.com, read 2026-05-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.